Keyphrases
Tumor Microenvironment
100%
Type-specific
100%
Intracellular Protein
100%
Immune Checkpoint Inhibitors
100%
Cancer Immunotherapy
100%
Lung Adenocarcinoma
50%
Kidney
50%
Cancer Cells
50%
Melanoma
50%
Tumor Progression
50%
Transcription Factor
50%
Cell Surface
50%
Cancer Tumor
50%
Therapeutic Response
50%
Immune Regulation
50%
Molecular Targets
50%
Family Protein
50%
Pro-survival
50%
B-cell Lymphoma 2 (Bcl-2)
50%
Nuclear Receptor
50%
Immunogenic Tumor
50%
Cancer Therapy
50%
Response Rate
50%
NR4A1
50%
Histone Deacetylase 1 (HDAC1)
50%
Epigenetic Regulators
50%
Histone Methyltransferase
50%
Immunogenic
50%
Cancer Therapeutics
50%
Lack of Response
50%
Survival Factor
50%
Tumor-promoting
50%
Non-immunogenic
50%
NR4A2
50%
Signal Transducer and Activator of Transcription 3
50%
LSD1
50%
KDM1A
50%
Bromodomain
50%
Multiple Cell Types
50%
Immune Checkpoint Molecules
50%
SET Domain
50%
Stoner Model
50%
Hot Tumor
50%
NR4A3
50%
Medicine and Dentistry
Tumor Microenvironment
100%
Immune Checkpoint Inhibitor
100%
Cancer Immunotherapy
100%
Cell Protein
100%
Malignant Neoplasm
50%
Neoplasm
50%
Cancer
50%
Tumor Progression
50%
Cancer Cell
50%
Immunomodulation
50%
Cancer Therapy
50%
Treatment Response
50%
Lung Adenocarcinoma
50%
Cell Surface
50%
B-Cell Lymphoma
50%
Histone Deacetylase
50%
Protein Family
50%
STAT3 Protein
50%
Cell Nucleus Receptor
50%
Kidney Carcinoma
50%
Melanoma
50%
Survival Factor
50%
Lysine
50%
Tumor
50%
Histone Lysine Methyltransferase
50%
Biochemistry, Genetics and Molecular Biology
Cancer Immunotherapy
100%
Lysine
100%
Immune Checkpoint Inhibitor
100%
Epigenetics
50%
Cancer Cell
50%
B Cell
50%
Tumor Progression
50%
Immunomodulation
50%
Histone Deacetylase
50%
Protein Family
50%
Nuclear Receptor
50%
Immune Checkpoints
50%
Methyltransferase
50%
STAT3
50%
Demethylase
50%
LSD1
50%
Bromodomain
50%
Survival Factor
50%
SET Domain
50%
Histone
50%
Immunology and Microbiology
Cancer Immunotherapy
100%
Histone
100%
Lysine
100%
Immune Checkpoint Inhibitor
100%
B Cell
50%
Cell Surface
50%
Cancer Cell
50%
Immunomodulation
50%
STAT3
50%
Protein Family
50%
Survival Factor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Immunotherapy
100%
Cell Protein
100%
Tumor Microenvironment
50%
Immune Checkpoint Inhibitor
50%
Neoplasm
25%
Tumor Growth
25%
B Cell Lymphoma
25%
Lung Adenocarcinoma
25%
Melanoma
25%
Molecular Target
25%
Lysine
25%
Histone Deacetylase
25%
STAT3 Protein
25%
Cell Nucleus Receptor
25%
Kidney Carcinoma
25%
Survival Factor
25%
Histone Lysine Methyltransferase
25%